New diabetes clinical trial: A Trial to Evaluate the Efficacy and Safety of ARO-INHBE in Adults With Metabolic Dysfunction-Associated Steatohepatitis
Published on: 2026-10-06T04:00:00Z
Conditions: Metabolic Dysfunction-Associated Steatohepatitis
Interventions: Drug: ARO-INHBE; Drug: Placebo
Sponsors: Arrowhead Pharmaceuticals
Not yet recruiting
https://ift.tt/mkNWHbi
Conditions: Metabolic Dysfunction-Associated Steatohepatitis
Interventions: Drug: ARO-INHBE; Drug: Placebo
Sponsors: Arrowhead Pharmaceuticals
Not yet recruiting
https://ift.tt/mkNWHbi
Comments
Post a Comment